Skip to main content

Actinic Keratosis

  • Chapter
  • First Online:
A Practical Guide to Skin Cancer

Abstract

Actinic keratosis (AK) is the most common precancerous skin lesion. AKs present on sun-damaged skin as pink to red gritty macules or papules. Patients with numerous AKs are at increased risk of developing skin cancer. AK development represents the initial step in keratinocytes’ progression to squamous cell carcinoma. Patients with numerous AKs are at increased risk of developing skin cancer. Treatment options for AKs include cryosurgery, topical chemotherapies, chemical peels, and laser surgery. Prevention is of utmost importance, including photoprotection such as sun protective clothing and sunscreens.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 109.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Rosen T, Lebwohl MG. Prevalence and awareness of actinic keratosis: barriers and opportunities. J Am Acad Dermatol. 2013;68(1):S2–9.

    Article  PubMed  Google Scholar 

  2. James WD, Elston DM, Berger TG, Elston DM. Epidermal nevi, neoplasms, and cysts. In: James WD, Berger TG, Elston DM, editors. Andrews' diseases of the skin. 12th ed. Philadelphia: Elsevier; 2016.

    Google Scholar 

  3. Chen GJ, Feldman SR, Williford PM, Hester EJ, Kiang S-H, Gill I, et al. Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer. Dermatol Surg. 2005;31(1):43–7.

    Article  PubMed  Google Scholar 

  4. Dodson JM. Malignant potential of actinic keratoses and the controversy over treatment. A patient-oriented perspective. AMA Dermatol. 1991;127(7):1029–31.

    Article  CAS  Google Scholar 

  5. Roewert-Huber J, Stockfleth E, Kerl H. Pathology and pathobiology of actinic (solar) keratosis - an update. Br J Dermatol. 2007;157(s2):18–20.

    Article  CAS  PubMed  Google Scholar 

  6. Nair PA, Chaudhary AH, Mehta MJ. Actinic keratosis underlying cutaneous horn at an unusual site— a case report. E Cancer Med Sci. 2013;7:376.

    Google Scholar 

  7. Soyer HP, Rigel DS, Wurm EMT. Actinic keratosis, basal cell carcinoma and squamous cell carcinoma. In: Bolognia J, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Philadelphia: Elsevier; 2012.

    Google Scholar 

  8. Zalaudek I, Ferrara G, Leinweber B, Mercogliano A, D'Ambrosio A, Argenziano G. Pitfalls in the clinical and dermoscopic diagnosis of pigmented actinic keratosis. J Am Acad Dermatol. 2005 Dec;53(6):1071–4.

    Article  PubMed  Google Scholar 

  9. Bagazgoitia L, Cuevas J, Expression JA. Of p53 and p16 in actinic keratosis, bowenoid actinic keratosis and Bowen's disease. J Eur Acad Dermatol Venereol. 2005;24(2):228–30.

    Article  CAS  Google Scholar 

  10. Rowert-Huber J, Patel MJ, Forschner T, Ulrich C, Eberle J, Kerl H, et al. Actinic keratosis is an early in situ squamous cell carcinoma: a proposal for reclassification. Br J Dermatol. 2007;156(3):8–12.

    Article  PubMed  Google Scholar 

  11. Werner RN, Stockfleth E, Connolly SM, Correia O, Erdmann R, Foley P, et al. Evidence- and consensus-based (S3) guidelines for the treatment of actinic keratosis - international league of dermatological societies in cooperation with the European dermatology forum - short version. J Eur Acad Dermatol Venereol. 2015;29(11):2069–79.

    Article  CAS  PubMed  Google Scholar 

  12. Trost LB, Bailin PL. Cryosurgery. In: Vidimos AT, Ammirati CT, Poblete-Lopez C, editors. Dermatologic surgery. Philadelphia: Elsevier; 2009.

    Google Scholar 

  13. Kuflik EG, Kuflik JH. Cryosurgery. In: Bolognia JL, Jorizzo JL, Schaffer JV, editors. Dermatology. 3rd ed. Philadelphia: Elsevier; 2012.

    Google Scholar 

  14. Pomerantz H, Hogan D, Eilers D. Long-term efficacy of topical fluorouracil cream, 5%, for treating actinic keratosis. JAMA Dermatol. 2015;151(9):952–60.

    Article  CAS  PubMed  Google Scholar 

  15. Askew DA, Mickan SM, Soyer HP, Wilkinson D. Effectiveness of 5-fluorouracil treatment for actinic keratosis – a systemic review of randomized controlled trials. Int J Dermatol. 2009;48(5):453–63.

    Article  CAS  PubMed  Google Scholar 

  16. Ritchie SA, Patel MJ, Miller SJ. Therapeutic options to decrease actinic keratosis and squa- mous cell carcinoma incidence and progression in solid organ transplant recipients: a practical approach. Dermatol Surg. 2012 May;38(10):1604–21.

    Article  CAS  PubMed  Google Scholar 

  17. Hanna E, Abadi R, Abbas O. Imiquimod in dermatology: an overview. Int J Dermatol. 2016;55(8):831–44.

    Article  CAS  PubMed  Google Scholar 

  18. Stockfleth E. Lmax and imiquimod 3.75%: the new standard in AK management. J Eur Acad Dermatol Venereol. 2015;29(Supp.1):9–14.

    Article  CAS  PubMed  Google Scholar 

  19. Ulrich C, Bichel J, Euvrard S, Guidi B, Proby CM, et al. Topical immunomodulation under systemic immunosuppression: results of a multicentre, randomized, placebo-controlled safety and efficacy study of imiquimod 5% cream for the treatment of actinic keratosis in kidney, heart, and liver transplant patients. Br J Dermatol. 2007;157(Suppl 2):25–31.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Jenkins SN, Speck K, Actinic CSC. Keratosis and bowen’s disease. In: Bigby M, Herxheimer A, editors. Evidence based dermatology. 3rd ed. Chichester, England: Wiley-Blackwell; 2014.

    Google Scholar 

  21. Gold MH. Lasers, photodynamic therapy, and the treatment of medical dermatological conditions. In: Goldberg DJ, editor. Laser dermatology. New York: Springer Publishing; 2005.

    Google Scholar 

  22. Hantash BM, Stewart DB, Cooper ZA. Facial resurfacing for nonmelanoma skin cancer prophylaxis. Arch Dermatol. 2006;142(8):976–82.

    Article  PubMed  Google Scholar 

  23. Iyer SS, Friedli A, Bowes L, Kricorian G. Full face laser resurfacing: therapy and prophylaxis for actinic keratosis and non-melanoma skin cancer. Lasers Surg Med. 2004;34(2):114–9.

    Article  PubMed  Google Scholar 

  24. Criscione VD, Weinstock MA, Naylor MF, Luque C, Eide MJ, Bingham SF, Department of Veterans Affairs Topical Tretinoin Chemoprevention Trial Group. Natural history and risk of malignant transformation in the veterans affairs topical Tretinoin chemoprevention trial. Cancer. 2009;115(11):2523–30.

    Article  PubMed  Google Scholar 

  25. Quaedvlieg PJ, Tirsi E, Thissen MR, Krekels GA. Actinic keratosis: how to differentiate the good from the bad ones? Eur J Dermatol. 2006;16(4):335–9.

    PubMed  CAS  Google Scholar 

  26. Madigan LM, Lim HW. Tanning beds: impact on health, and recent regulations. Clin Dermatol. 2016;34(5):640–8.

    Article  PubMed  Google Scholar 

  27. Nikolaou V, Stratigos AJ, Tsao H. Hereditary nonmelanoma skin cancer. Semin Cutan Med Surg. 2012;31(4):204–10.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Naylor MF, Boyd A, Smith DW, Cameron GS, Hubbard D, Neldner KH. High sun protection factor sunscreens in the suppression of actinic neoplasia. Arch Dermatol. 1995;131(2):170–5.

    Article  CAS  PubMed  Google Scholar 

  29. Darlington S, Williams G, Neale R, Frost C, Green A. A randomized controlled trial to assess sunscreen application and beta carotene supplementation in the prevention of solar keratoses. Arch Dermatol. 2003;139(4):451–5.

    Article  PubMed  Google Scholar 

  30. Thompson SC, Jolley D, Marks R. Reduction of solar keratoses by regular sunscreen use. N Engl J Med. 1993;329(16):1147–51.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Allison Pye .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2018 Springer International Publishing AG, part of Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Pye, A., Wallis, D., Mishra, V. (2018). Actinic Keratosis. In: Hanlon, A. (eds) A Practical Guide to Skin Cancer. Springer, Cham. https://doi.org/10.1007/978-3-319-74903-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-74903-7_2

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-74901-3

  • Online ISBN: 978-3-319-74903-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics